Kylene Kehn-Hall

Dr. Kylene Kehn-Hall received her Ph.D. in Biochemistry and Molecular Biology from The George Washington University (GWU) studying retroviral pathogenesis and breast cancer biology. She went on to do her post-doctoral research at the FBI Counterterrorism and Forensic Science Research Lab, focusing on application-based science and assay development. In 2007 she took a Research Scientist position within Dr. Sina Bavari's laboratory at the United States Army Medical Research Institute of Infectious Disease (USAMRIID), where she worked towards high throughput assay development and the identification of novel therapeutics for hemorrhagic fever viruses. Prior to coming to George Mason University, Dr. Kehn-Hall was an Assistant Research Professor in the Department of Microbiology, Immunology, and Tropical Medicine at GWU, where she continued her work on HIV and HTLV-1 studying the host response to viral infection. Currently, she is a tenure-track Assistant Professor in the National Center for Biodefense and Infectious Diseases and the School of Systems Biology. Dr. Kehn-Hall's research is focused on the development of diagnostics and therapeutics for emerging infectious diseases, specifically Bunyaviruses, Alphaviruses, and HIV. Proteomics (membrane, serum, and phospho) and miRNA profiling technologies are being used to identify cellular targets for viral inhibition as well as biomarkers for disease.